enGene Common Stock Statistics
Share Statistics
enGene Common Stock has 50.98M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 50.98M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 919 |
| FTD / Avg. Volume | 0.47% |
Short Selling Information
The latest short interest is 797.34K, so 1.56% of the outstanding shares have been sold short.
| Short Interest | 797.34K |
| Short % of Shares Out | 1.56% |
| Short % of Float | 4.3% |
| Short Ratio (days to cover) | 3.74 |
Valuation Ratios
The PE ratio is -4.64 and the forward PE ratio is -5.04.
| PE Ratio | -4.64 |
| Forward PE | -5.04 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 6.4 |
| P/FCF Ratio | -18.51 |
| PEG Ratio | n/a |
Enterprise Valuation
enGene Inc. Common Stock has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 16.25, with a Debt / Equity ratio of 0.13.
| Current Ratio | 16.25 |
| Quick Ratio | 16.25 |
| Debt / Equity | 0.13 |
| Total Debt / Capitalization | 11.89 |
| Cash Flow / Debt | -2.53 |
| Interest Coverage | -5.26 |
Financial Efficiency
Return on equity (ROE) is -1.38% and return on capital (ROIC) is -31.68%.
| Return on Equity (ROE) | -1.38% |
| Return on Assets (ROA) | -1.15% |
| Return on Capital (ROIC) | -31.68% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -3.22M |
| Employee Count | 31 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 17.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -17.86% in the last 52 weeks. The beta is -0.76, so enGene Common Stock's price volatility has been lower than the market average.
| Beta | -0.76 |
| 52-Week Price Change | -17.86% |
| 50-Day Moving Average | 8.19 |
| 200-Day Moving Average | 10.3 |
| Relative Strength Index (RSI) | 29.67 |
| Average Volume (20 Days) | 196.50K |
Income Statement
In the last 12 months, enGene Common Stock had revenue of $0 and earned -$99.92M in profits. Earnings per share was $-4.51.
| Revenue | 0 |
| Gross Profit | -175.00K |
| Operating Income | -26.06M |
| Net Income | -99.92M |
| EBITDA | -94.77M |
| EBIT | - |
| Earnings Per Share (EPS) | -4.51 |
Balance Sheet
The company has $81.52M in cash and $9.78M in debt, giving a net cash position of $71.74M.
| Cash & Cash Equivalents | 81.52M |
| Total Debt | 9.78M |
| Net Cash | 71.74M |
| Retained Earnings | -199.59M |
| Total Assets | 266.88M |
| Working Capital | 249.24M |
Cash Flow
In the last 12 months, operating cash flow was -$24.74M and capital expenditures -$318.00K, giving a free cash flow of -$25.06M.
| Operating Cash Flow | -24.74M |
| Capital Expenditures | -318.00K |
| Free Cash Flow | -25.06M |
| FCF Per Share | -1.08 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
ENGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -74.3% |
| FCF Yield | -8.1% |
Analyst Forecast
The average price target for ENGN is $31, which is 410.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $31 |
| Price Target Difference | 410.7% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Scores
| Altman Z-Score | 3.91 |
| Piotroski F-Score | 3 |